1. Home
  2. DNA vs AIO Comparison

DNA vs AIO Comparison

Compare DNA & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

SELL

Current Price

$8.50

Market Cap

835.7M

Sector

Health Care

ML Signal

SELL

Logo Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

AIO

Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

SELL

Current Price

$22.89

Market Cap

927.8M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
DNA
AIO
Founded
2008
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
835.7M
927.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DNA
AIO
Price
$8.50
$22.89
Analyst Decision
Sell
Analyst Count
3
0
Target Price
★ $8.00
N/A
AVG Volume (30 Days)
★ 2.4M
99.3K
Earning Date
11-05-2026
01-01-0001
Dividend Yield
N/A
★ 9.05%
EPS Growth
★ 46.49
N/A
EPS
N/A
★ N/A
Revenue
★ $170,155,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.59
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.37
$20.91
52 Week High
$18.22
$28.60

Technical Indicators

Market Signals
Indicator
DNA
AIO
Relative Strength Index (RSI) 40.61 42.72
Support Level $6.65 $22.56
Resistance Level $10.34 $23.55
Average True Range (ATR) 1.53 0.67
MACD -0.30 0.07
Stochastic Oscillator 2.03 37.12

Price Performance

Historical Comparison
DNA
AIO

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.

Share on Social Networks: